Is Nutex Health Stock a Good Investment?
Nutex Health Investment Advice | NUTX |
- Examine Nutex Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nutex Health's leadership team and their track record. Good management can help Nutex Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Nutex Health's business and its evolving consumer preferences.
- Compare Nutex Health's performance and market position to its competitors. Analyze how Nutex Health is positioned in terms of product offerings, innovation, and market share.
- Check if Nutex Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nutex Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nutex Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nutex Health is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Nutex Health Stock
Researching Nutex Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 39.0% of the company outstanding shares are owned by corporate insiders. The book value of Nutex Health was now reported as 11.59. The company recorded a loss per share of 9.18. Nutex Health last dividend was issued on the 1st of November 2019. The entity had 1:10 split on the 3rd of July 2024.
To determine if Nutex Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nutex Health's research are outlined below:
| Nutex Health is way too risky over 90 days horizon | |
| Nutex Health appears to be risky and price may revert if volatility continues | |
| Nutex Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 247.65 M. Net Loss for the year was (45.79 M) with profit before overhead, payroll, taxes, and interest of 36.3 M. | |
| About 39.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investing.com: Freedom Capital Markets bullish on Nutex Health stock |
Nutex Health Quarterly Good Will |
|
Nutex Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nutex Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nutex Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Nutex Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Nutex Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -0.005 | -0.01 | -0.005 | 100 | ||
2023-03-02 | 2022-12-31 | -0.01 | -0.02 | -0.01 | 100 | ||
2024-03-28 | 2023-12-31 | -0.005 | -0.0467 | -0.0417 | 834 | ||
2024-08-08 | 2024-06-30 | -0.29 | -0.07 | 0.22 | 75 | ||
2024-11-07 | 2024-09-30 | -0.24 | -1.72 | -1.48 | 616 |
Know Nutex Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nutex Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nutex Health backward and forwards among themselves. Nutex Health's institutional investor refers to the entity that pools money to purchase Nutex Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Atwood & Palmer Inc | 2024-09-30 | 13.0 | Creative Planning Inc | 2024-06-30 | 0.0 | State Street Corp | 2024-06-30 | 0.0 | Point72 Asia (singapore) Pte. Ltd | 2024-06-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Tower Research Capital Llc | 2024-06-30 | 0.0 | Wealth Enhancement Advisory Services, Llc | 2024-06-30 | 0.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Wealthcare Advisory Partners Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 92 K | Essex Investment Management Company, Llc | 2024-09-30 | 72.8 K |
Nutex Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 178.93 M.Market Cap |
|
Nutex Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.13) | (0.13) | |
| Return On Capital Employed | (0.09) | (0.09) | |
| Return On Assets | (0.11) | (0.12) | |
| Return On Equity | (0.75) | (0.71) |
Determining Nutex Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Nutex Health is a good buy. For example, gross profit margin measures Nutex Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nutex Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Nutex Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutex Health. Check Nutex Health's Beneish M Score to see the likelihood of Nutex Health's management manipulating its earnings.
Evaluate Nutex Health's management efficiency
Nutex Health has return on total asset (ROA) of 0.0376 % which means that it generated a profit of $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.351) %, meaning that it created substantial loss on money invested by shareholders. Nutex Health's management efficiency ratios could be used to measure how well Nutex Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.13 in 2024. Return On Capital Employed is likely to rise to -0.09 in 2024. At this time, Nutex Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 322.8 M in 2024, whereas Total Current Assets are likely to drop slightly above 53.7 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.94 | 18.84 | |
| Tangible Book Value Per Share | 9.42 | 9.89 | |
| Enterprise Value Over EBITDA | (25.57) | (26.84) | |
| Price Book Value Ratio | 1.94 | 1.84 | |
| Enterprise Value Multiple | (25.57) | (26.84) | |
| Price Fair Value | 1.94 | 1.84 | |
| Enterprise Value | 7.9 B | 8.3 B |
Understanding the operational decisions made by Nutex Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 1.789 |
Basic technical analysis of Nutex Stock
As of the 23rd of November, Nutex Health secures the Downside Deviation of 5.8, risk adjusted performance of 0.1022, and Mean Deviation of 5.46. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nutex Health, as well as the relationship between them.Nutex Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nutex Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nutex Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nutex Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nutex Health's Outstanding Corporate Bonds
Nutex Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nutex Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nutex bonds can be classified according to their maturity, which is the date when Nutex Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NUTRIEN LTD 3 Corp BondUS67077MAD02 | View | |
| NUTRIEN LTD 4 Corp BondUS67077MAE84 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| NTRCN 395 13 MAY 50 Corp BondUS67077MAX65 | View | |
| NTRCN 595 07 NOV 25 Corp BondUS67077MAY49 | View | |
| US67077MAZ14 Corp BondUS67077MAZ14 | View | |
| NUTRIEN LTD Corp BondUS67077MAT53 | View | |
| NUTRIEN LTD Corp BondUS67077MAU27 | View |
Understand Nutex Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nutex Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1022 | |||
| Market Risk Adjusted Performance | 0.615 | |||
| Mean Deviation | 5.46 | |||
| Semi Deviation | 5.3 | |||
| Downside Deviation | 5.8 | |||
| Coefficient Of Variation | 822.73 | |||
| Standard Deviation | 7.42 | |||
| Variance | 55.04 | |||
| Information Ratio | 0.1039 | |||
| Jensen Alpha | 0.7137 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.133 | |||
| Treynor Ratio | 0.605 | |||
| Maximum Drawdown | 47.75 | |||
| Value At Risk | (9.19) | |||
| Potential Upside | 11.28 | |||
| Downside Variance | 33.62 | |||
| Semi Variance | 28.04 | |||
| Expected Short fall | (6.29) | |||
| Skewness | 1.37 | |||
| Kurtosis | 5.24 |
| Risk Adjusted Performance | 0.1022 | |||
| Market Risk Adjusted Performance | 0.615 | |||
| Mean Deviation | 5.46 | |||
| Semi Deviation | 5.3 | |||
| Downside Deviation | 5.8 | |||
| Coefficient Of Variation | 822.73 | |||
| Standard Deviation | 7.42 | |||
| Variance | 55.04 | |||
| Information Ratio | 0.1039 | |||
| Jensen Alpha | 0.7137 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.133 | |||
| Treynor Ratio | 0.605 | |||
| Maximum Drawdown | 47.75 | |||
| Value At Risk | (9.19) | |||
| Potential Upside | 11.28 | |||
| Downside Variance | 33.62 | |||
| Semi Variance | 28.04 | |||
| Expected Short fall | (6.29) | |||
| Skewness | 1.37 | |||
| Kurtosis | 5.24 |
Consider Nutex Health's intraday indicators
Nutex Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nutex Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nutex Health Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 26th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 25th of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Nutex Stock media impact
Far too much social signal, news, headlines, and media speculation about Nutex Health that are available to investors today. That information is available publicly through Nutex media outlets and privately through word of mouth or via Nutex internal channels. However, regardless of the origin, that massive amount of Nutex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nutex Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nutex Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nutex Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nutex Health alpha.
Nutex Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Nutex Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Nutex Health Corporate Management
| Vivian MBA | Director Marketing | Profile | |
| BSN JD | Chief Sec | Profile | |
| Elizabeth Hall | HR Mang | Profile | |
| Jon Bates | Chief Officer | Profile | |
| MD MBA | Chairman CEO | Profile | |
| Lawrence FACS | Chief Officer | Profile |
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.